Skip to content

Clinical trials

Neoplasm Metastasis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Hong Kong Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20064
20072
20084
20093
20103
20111
20123
20131
20143
20151
20162
20182
20194
20202
20215
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting9
Terminated8
Recruiting4
Approved for marketing1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Pfizer4
AstraZeneca3
Chinese University of Hong Kong3
The University of Hong Kong3
Amgen2
Bayer2
Clovis Oncology, Inc.2
GlaxoSmithKline2
NRG Oncology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis47
Breast Neoplasms12
Carcinoma, Non-Small-Cell Lung10
Neoplasms9
Colorectal Neoplasms7
Carcinoma, Renal Cell4
Lung Neoplasms4
Recurrence4
Brain Neoplasms3
Colonic Neoplasms3

Trials

Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.